The Street is wrecked over the Actavis integration and Copaxone competition. Teva Pharma (TEVA) is a gorilla and the 3-5 year outlook is pretty good. The Value Line low total return forecast is approximately 15% and TEVA landed at the top of of this week's Fave Five: https://expectingalpha.com/2016/12/01/fave-five-1222016-2/ [more]
Adding Mercadolibre (MELI), Mesa Labs (MLAB) and Forward Air (FWRD) to our CAPS tracking portfolio.
World leader in diabetes solutions. Our financial analysis summarized at: https://expectingalpha.com/2016/10/07/novo-nordisk-nvo/
A panorama of the stuff we look at ... using Fastenal (FAST) the 4th most widely-followed stock by Manifest Investing subscribers. https://expectingalpha.com/2016/06/21/fastenal-fast/
We use our return-based methods to generate our own howling Dogs. The Top Five for 2015 delivered an 18.2% average total return and the Bottom Five, 1.8%. This year's Dashing Dogs are: Pfizer (PFE), United Health (UNH), Merck (MRK), Cisco Systems (CSCO) and NIKE (NKE). For more, see: http://expectingalpha.com/2016/01/23/dogs-of-the-dow-howling-again/ [more]